Biopsy-proven LN Class III/IVÂ±V (ISN/RPS 2003), with biopsy performed within 12 weeks of randomization.
Positive anti-dsDNA.
Active LN with proteinuria (urine protein/creatinine ratio >1.0 or 24-hr urine protein >1.0 g at baseline), with or without hematuria.
Both 'incident' (i.e. new) patients and 'flare' patients can be included.
